Takahide Kaneko
Overview
Explore the profile of Takahide Kaneko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saikawa M, Kimura U, Ikari Y, Miyata A, Kaneko T, Hiruma M, et al.
Med Mycol J
. 2024 Dec;
65(4):103-106.
PMID: 39617457
A man in his thirties patient visited his previous physician with the chief complaint of a pigmented macule on the sole of his left foot that had steadily grown over...
2.
Toyosawa Y, Komiya E, Kaneko T, Suga Y, Tominaga M, Takamori K
J Dermatol Sci
. 2024 Nov;
PMID: 39616021
Background: Mechanical alloknesis (m-alloknesis) is itch hypersensitivity induced by normally innocuous stimuli. It is sometimes observed in dry skin based itch-related diseases such as atopic dermatitis (AD), and often triggers...
3.
Kojima G, Komiya E, Honda K, Kaneko T, Suga Y, Tominaga M, et al.
Acta Derm Venereol
. 2024 May;
104:adv39950.
PMID: 38751178
Pruritus in the elderly, particularly those cases without skin dryness or other identifiable causes, makes treatment challenging due to the lack of evidence regarding the therapeutic effects of antipruritics. This...
4.
Kamata Y, Kato R, Tominaga M, Toyama S, Komiya E, Utsumi J, et al.
JID Innov
. 2024 Apr;
4(3):100271.
PMID: 38585194
Hand-foot skin reaction is the most common adverse event of multikinase inhibitors, such as sorafenib. Although hand-foot skin reaction is not life threatening, severe cases impair quality of life because...
5.
Mori T, Namikawa K, Yamazaki N, Kiniwa Y, Yamasaki O, Yoshikawa S, et al.
Front Med (Lausanne)
. 2023 Aug;
10:1229937.
PMID: 37636577
Background: Anti-programmed cell death protein 1 (PD-1) monotherapy is one of the standard systemic therapies for advanced melanoma; however, the efficacy of salvage systemic therapies after PD-1 monotherapy failure (PD-1...
6.
Tsurumachi M, Kamata Y, Tominaga M, Ishikawa J, Hideshima T, Shimizu E, et al.
J Dermatol Sci
. 2023 Apr;
110(1):2-9.
PMID: 37003921
Background: Bleomycin hydrolase (BH), which is expressed in the stratum granulosum and lower stratum corneum (SC), is involved in final filaggrin degradation. Furthermore, BH plays an essential role in producing...
7.
Kishi R, Toyama S, Tominaga M, Kamata Y, Komiya E, Kaneko T, et al.
Cells
. 2023 Jan;
12(2).
PMID: 36672173
Dupilumab attenuates itch and skin inflammation in patients with atopic dermatitis (AD). However, itch-related events that are improved by dupilumab remain unclear. Therefore, the present study investigated changes in clinical...
8.
Nakamura Y, Namikawa K, Kiniwa Y, Kato H, Yamasaki O, Yoshikawa S, et al.
Eur J Cancer
. 2022 Oct;
176:78-87.
PMID: 36194906
Background: Although anti-PD-1 antibody monotherapy (PD-1) is commonly used to treat advanced acral melanoma (AM), its efficacy is limited. Further, data on the efficacy of PD-1 plus anti-CTLA-4 antibody (PD-1+CTLA-4)...
9.
Umeda Y, Yoshikawa S, Kiniwa Y, Maekawa T, Yamasaki O, Isei T, et al.
Eur J Cancer
. 2021 Sep;
157:361-372.
PMID: 34563991
Background: Immune checkpoint inhibitors (ICIs) have a lower efficacy in mucosal melanoma (MUM) than in cutaneous melanoma. The use of combination treatments with radiotherapy (RT) to improve the efficacy in...
10.
Asari T, Rokunohe D, Sasaki E, Kaneko T, Kumagai G, Wada K, et al.
J Orthop Sci
. 2020 Dec;
27(1):266-271.
PMID: 33349545
Background: This study aimed to assess orthopedic surgeons' attitudes and behaviors toward occupational radiation exposure and investigate the prevalence of occupational radiation-induced skin injury among orthopedic surgeons. Similarly, risk factors...